Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Alimentary Pharmacology & Therapeutics
|
July 12, 2008
Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients
E Coron, V Sebille, G Cadiot, et al.
Gut
|
August 13, 2002
Fatigue is associated with high circulating leptin levels in chronic hepatitis C
T Piche, E Gelsi, S M Schneider, et al.
Gut
|
July 24, 2013
Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation
M Vivinus-Nébot, G Frin-Mathy, H Bzioueche, et al.
Gut
|
January 16, 2008
Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome
T Piche, M C Saint-Paul, R Dainese, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 25, 2020
Expectations of IBS patients concerning disease and healthcare providers: Results of a prospective survey among members of a French patients' association
J M Sabaté, P Ducrotté, T Piche, et al.
The American Journal of Gastroenterology
|
September 21, 2011
Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells
M Vivinus-Nébot, R Dainese, R Anty, et al.
Gut
|
July 13, 2005
Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study
T Piche, G Vanbiervliet, F Cherikh, et al.
Gastroenterologie Clinique Et Biologique
|
August 30, 2000
Non invasive prediction of severe fibrosis in patients with alcoholic liver disease
A Tran, P Hastier, E M Barjoan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2025
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial
C Lepage, J-M Phelip, L Cany, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Alimentary Pharmacology & Therapeutics
|
July 12, 2008
Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients
E Coron, V Sebille, G Cadiot, et al.
Gut
|
August 13, 2002
Fatigue is associated with high circulating leptin levels in chronic hepatitis C
T Piche, E Gelsi, S M Schneider, et al.
Gut
|
July 24, 2013
Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation
M Vivinus-Nébot, G Frin-Mathy, H Bzioueche, et al.
Gut
|
January 16, 2008
Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome
T Piche, M C Saint-Paul, R Dainese, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 25, 2020
Expectations of IBS patients concerning disease and healthcare providers: Results of a prospective survey among members of a French patients' association
J M Sabaté, P Ducrotté, T Piche, et al.
The American Journal of Gastroenterology
|
September 21, 2011
Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells
M Vivinus-Nébot, R Dainese, R Anty, et al.
Gut
|
July 13, 2005
Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study
T Piche, G Vanbiervliet, F Cherikh, et al.
Gastroenterologie Clinique Et Biologique
|
August 30, 2000
Non invasive prediction of severe fibrosis in patients with alcoholic liver disease
A Tran, P Hastier, E M Barjoan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2025
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial
C Lepage, J-M Phelip, L Cany, et al.
Page
of 4